In breast cancer, TET2 knockout results in an increase in m5C of most enhancers and a significant reduction in of H3K4me1 and H3K27ac enrichment, which jointly promoted the tumorigenesis of ERα-positive MCF7 breast cancer cells [20]. This evidence concerns the gene TET2 and breast carcinoma.